Home » Topics » BioWorld Science

BioWorld Science
RSS

Checkpoint Therapeutics reports interim data from phase I trial of cosibelimab

May 2, 2019

FDA issues complete response letter for HTX-011 for postoperative pain

May 2, 2019

Genkyotex reports topline phase II data for GKT-831 in primary biliary cholangitis

May 2, 2019

NexImmune and MMRF partner to advance NEXI-002 for multiple myeloma

May 2, 2019

MCT 4 lactate transporter inhibitor AZD-0095 targets immunosuppression in tumors

May 2, 2019

Merck & Co. describes new LRRK2 inhibitors

May 2, 2019

Bristol-Myers Squibb patents IDO-1 inhibitors

May 2, 2019

Shanghai Institute of Materia Medica discloses new antibacterials

May 2, 2019

FDA approves Dengvaxia for prevention of dengue infection in endemic areas

May 2, 2019

New phase II trial investigates BPN-14770 in early Alzheimer's disease

May 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...